These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 9682349
1. A benefit-cost analysis of two-dose measles immunization in Canada. Pelletier L, Chung P, Duclos P, Manga P, Scott J. Vaccine; 1998; 16(9-10):989-96. PubMed ID: 9682349 [Abstract] [Full Text] [Related]
2. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study. Bae GR, Choe YJ, Go UY, Kim YI, Lee JK. Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654 [Abstract] [Full Text] [Related]
5. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278 [Abstract] [Full Text] [Related]
6. Catch-up immunization programs will eliminate measles threat for most schoolchildren. Rafuse J. CMAJ; 1996 May 15; 154(10):1567-8. PubMed ID: 8625011 [Abstract] [Full Text] [Related]
7. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. MMWR Recomm Rep; 1998 May 22; 47(RR-8):1-57. PubMed ID: 9639369 [Abstract] [Full Text] [Related]
8. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease Control and Prevention. MMWR Recomm Rep; 2013 Jun 14; 62(RR-04):1-34. PubMed ID: 23760231 [Abstract] [Full Text] [Related]
9. Benefits, risks and costs of immunization for measles, mumps and rubella. White CC, Koplan JP, Orenstein WA. Am J Public Health; 1985 Jul 14; 75(7):739-44. PubMed ID: 3923849 [Abstract] [Full Text] [Related]
12. From the Centers for Disease Control and Prevention. Measles--United States, 1996, and the interruption of indigenous transmission. JAMA; 1997 May 07; 277(17):1345-6. PubMed ID: 9134928 [No Abstract] [Full Text] [Related]
14. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W. Przegl Epidemiol; 1993 May 07; 47(1-2):47-53. PubMed ID: 8351387 [Abstract] [Full Text] [Related]
19. Measles-mumps-rubella immunization of susceptible hospital employees during a community measles outbreak: cost-effectiveness and protective efficacy. Stover BH, Adams G, Kuebler CA, Cost KM, Rabalais GP. Infect Control Hosp Epidemiol; 1994 Jan 15; 15(1):18-21. PubMed ID: 8133004 [Abstract] [Full Text] [Related]
20. Measles-rubella mass immunization campaign in Albania, November 2000. Bino S, Kakarriqi E, Xibinaku M, Ion-Nedelcu N, Bukli M, Emiroglu N, Uzicanin A. J Infect Dis; 2003 May 15; 187 Suppl 1():S223-9. PubMed ID: 12721917 [Abstract] [Full Text] [Related] Page: [Next] [New Search]